全文获取类型
收费全文 | 5502篇 |
免费 | 358篇 |
国内免费 | 25篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 157篇 |
妇产科学 | 133篇 |
基础医学 | 778篇 |
口腔科学 | 129篇 |
临床医学 | 494篇 |
内科学 | 1582篇 |
皮肤病学 | 90篇 |
神经病学 | 303篇 |
特种医学 | 86篇 |
外科学 | 635篇 |
综合类 | 52篇 |
一般理论 | 2篇 |
预防医学 | 408篇 |
眼科学 | 121篇 |
药学 | 301篇 |
1篇 | |
中国医学 | 46篇 |
肿瘤学 | 522篇 |
出版年
2024年 | 6篇 |
2023年 | 66篇 |
2022年 | 89篇 |
2021年 | 190篇 |
2020年 | 94篇 |
2019年 | 172篇 |
2018年 | 163篇 |
2017年 | 121篇 |
2016年 | 115篇 |
2015年 | 147篇 |
2014年 | 198篇 |
2013年 | 285篇 |
2012年 | 472篇 |
2011年 | 437篇 |
2010年 | 270篇 |
2009年 | 205篇 |
2008年 | 342篇 |
2007年 | 395篇 |
2006年 | 350篇 |
2005年 | 363篇 |
2004年 | 343篇 |
2003年 | 321篇 |
2002年 | 259篇 |
2001年 | 24篇 |
2000年 | 16篇 |
1999年 | 34篇 |
1998年 | 36篇 |
1997年 | 26篇 |
1996年 | 39篇 |
1995年 | 17篇 |
1994年 | 29篇 |
1993年 | 17篇 |
1992年 | 13篇 |
1991年 | 15篇 |
1990年 | 11篇 |
1989年 | 7篇 |
1988年 | 14篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 15篇 |
1984年 | 15篇 |
1983年 | 10篇 |
1982年 | 8篇 |
1981年 | 15篇 |
1980年 | 13篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1976年 | 10篇 |
1975年 | 10篇 |
1959年 | 4篇 |
排序方式: 共有5885条查询结果,搜索用时 15 毫秒
81.
Peggs KS Sureda A Qian W Caballero D Hunter A Urbano-Ispizua A Cavet J Ribera JM Parker A Canales M Mahendra P Garcia-Conde J Milligan D Sanz G Thomson K Arranz R Goldstone AH Alvarez I Linch DC Sierra J Mackinnon S;UK Spanish Collaborative Groups 《British journal of haematology》2007,139(1):70-80
The introduction of reduced-intensity conditioning (RIC) has enabled the role of allogeneic transplantation to be re-evaluated in Hodgkin lymphoma (HL). While T-cell depletion reduces graft-versus-host disease (GvHD), it potentially abrogates graft-versus-tumour activity and increases infective complications. We compared the results in 67 sibling donor transplantations following RIC in multiply relapsed patients from two national phase II studies conditioned with fludarabine/melphalan. One used cyclosporine/alemtuzumab (MF-A, n = 31), the other used cyclosporine/methotrexate (MF, n = 36) as GvHD prophylaxis. There was a small excess of chemorefractory cases in the MF cohort (P = NS). MF-A resulted in significantly lower incidences of non-relapse mortality, acute and chronic GvHD, but no significant excess of relapse/progression. Post donor lymphocyte infusion (DLI) disease responses occurred in 8/14 (57%) and 6/11 (55%) patients in the MF-A and MF groups, respectively. Current progression-free survival (CPFS) was superior with MF-A (univariate analysis), with durable responses to DLI contributing to the favourable outcome (43% vs. 25%, P = 0.0356). Disease status at transplantation significantly influenced overall survival (P = 0.0038) and CPFS (P = 0.0014), retaining significance in multivariate analyses, which demonstrated a trend towards improved CPFS with T-cell depletion (P = 0.0939). These data suggest that alemtuzumab significantly reduced GvHD without resulting in a deleterious impact on survival outcomes following RIC in HL, and that durable responses to DLI may be more common following the inclusion of alemtuzumab in the conditioning protocol. 相似文献
82.
83.
Kenneth Wengler Brandon K. Ashinoff Elena Pueraro Clifford M. Cassidy Guillermo Horga Bret R. Rutherford 《Neuropsychopharmacology》2021,46(7):1233
Late-life depression (LLD) is a prevalent and disabling condition in older adults that is often accompanied by slowed processing and gait speed. These symptoms are related to impaired dopamine function and sometimes remedied by levodopa (L-DOPA). In this study, we recruited 33 older adults with LLD to determine the association between a proxy measure of dopamine function—neuromelanin-sensitive magnetic resonance imaging (NM-MRI)—and baseline slowing measured by the Digit Symbol test and a gait speed paradigm. In secondary analyses, we also assessed the ability of NM-MRI to predict L-DOPA treatment response in a subset of these patients (N = 15) who received 3 weeks of L-DOPA. We scanned a further subset of these patients (N = 6) with NM-MRI at baseline and after treatment to preliminarily evaluate the effects of L-DOPA treatment on the NM-MRI signal. We found that lower baseline NM-MRI correlated with slower baseline gait speed (346 of 1807 substantia nigra–ventral tegmental area (SN-VTA) voxels, Pcorrected = 0.038), particularly in the more medial, anterior, and dorsal SN-VTA. Secondary analyses failed to show an association between baseline NM-MRI and treatment-related changes in gait speed, processing speed, or depression severity (all Pcorrected > 0.361); we however found preliminary evidence of increases in the NM-MRI signal 3 weeks post-treatment with L-DOPA compared to baseline (200 of 1807 SN-VTA voxels; Pcorrected = 0.046), although the small sample size of these preliminary analyses warrants caution in their interpretation and future replications. Overall, our findings indicate that NM-MRI is sensitive to variability in gait speed in patients with LLD, suggesting this non-invasive MRI measure may provide a promising marker for dopamine-related psychomotor slowing in geriatric neuropsychiatry.Subject terms: Cognitive neuroscience, Depression, Biomarkers 相似文献
84.
Guillermo Quindós Elena Eraso Leyre M. López-Soria Guillermo Ezpeleta 《Enfermedades infecciosas y microbiología clínica》2012
Diagnosis of invasive mycoses is a difficult challenge due to the limitations and low sensitivity of traditional microbiology methods which lead to diagnostic and therapeutic delays. The aim of this review is to summarise the state of the art of the molecular diagnosis of invasive fungal disease and to clarify its current role in the clinical practice. Conventional microbiological methods could be complemented with molecular methods in the rapid and definitive identification of fungal isolates. Biomarkers (β-glucan, galactomannan) are very useful in immunocompromised patients and have been included as probable invasive mycoses by the EORTC/MSG. Nucleic acid detection is currently used as a complementary tool for diagnosis. However, PCR can be very useful in mould invasive mycoses. Finally, the combined detection using biomarkers can improve the diagnosis. However, their applicability in the microbiology laboratory is not so easy and further studies are required for the appropriate evaluation of its clinical usefulness. 相似文献
85.
86.
Sandra M. Blois Flavia Piccioni Nancy Freitag Irene Tirado-González Petra Moschansky Rodrigo Lloyd Karin Hensel-Wiegel Matthias Rose Mariana G. Garcia Laura D. Alaniz Guillermo Mazzolini 《Angiogenesis》2014,17(1):119-128
During liver fibrogenesis the immune response and angiogenesis process are fine-tuned resulting in activation of hepatic stellate cells that produce an excess of extracellular matrix proteins. Dendritic cells (DC) play a central role modulating the liver immunity and have recently been implicated to favour fibrosis regression; although their ability to influence the development of fibrogenesis is unknown. Therefore, we explored whether the depletion of DC during early stages of liver injury has an impact in the development of fibrogenesis. Using the CD11c.DTR transgenic mice, DC were depleted in two experimental models of fibrosis in vivo. The effect of anti-angiogenic therapy was tested during early stages of liver fibrogenesis. DC depletion accelerates the development of fibrosis and as a consequence, the angiogenesis process is boosted. We observed up-regulation of pro-angiogenic factors together with an enhanced vascular endothelial growth factor (VEGF) bioavailability, mainly evidenced by the decrease of anti-angiogenic VEGF receptor 1 (also known as sFlt-1) levels. Interestingly, fibrogenesis process enhanced the expression of Flt-1 on hepatic DC and administration of sFlt-1 was sufficient to abrogate the acceleration of fibrogenesis upon DC depletion. Thus, DC emerge as novel players during the development of liver fibrosis regulating the angiogenesis process and thereby influencing fibrogenesis. 相似文献
87.
88.
89.
90.
Time Frames for Analysis of Inflammatory Mediators in Acute Pancreatitis: Improving Admission Triage
Andrés Duarte-Rojo Jorge Suazo-Barahona María Teresa Ramírez-Iglesias Luis F. Uscanga Guillermo Robles-Díaz 《Digestive diseases and sciences》2009,54(10):2282-2287
Improving the outcome of acute pancreatitis through prognostic markers has been a matter of ample research. We evaluate the
clinical usefulness of four serum markers in comparison to Ranson’s score. Serum measurements of C-reactive protein (CRP),
interleukin-6, -10 (IL-6, IL-10), and pancreatitis-associated protein (PAP) were performed. The usefulness of each marker
for predicting severity was compared with that of Ranson’s score. Time of evolution was considered for improving their usefulness.
Seventy-one patients were studied. Severe cases had higher levels of all markers, although only IL-10 had better accuracy
than Ranson’s. In patients admitted during the first 48 h, IL-6, IL-10, and PAP had improved accuracy over Ranson’s; however,
after this time frame, only CRP outperformed Ranson’s score. Analysis of time frames improved the accuracy of all markers.
Therefore, time of evolution should be considered when using these parameters for a better prognosis. 相似文献